The LPD group also exhibited reduced gut inflammation, characterized by decreased levels of pro‐inflammatory cytokines (IL‐6, IL‐8, IL‐12, IFN‐γ, TLR4, and TLR2) and increased anti‐inflammatory cytokines (IL‐4 and TGF‐β) (Figure 6S,T). The gene discussed is TLR4; the disease is disseminated peritoneal leiomyomatosis.